Skip to content

Toxicology Letters

ISSN 1879-3169, 0378-4274

22 papers in the library · 124 citations · publishing 1998-2025

Papers

Sort Most recent Most cited

Lithium attenuates ketamine-induced long-term neurotoxicity through DISC1-mediated GSK-3β/β-catenin and ERK/CREB pathways.

Toxicology Letters April 1, 2025 Ting-Ting Yang, Zi-Wen Guo, Fang Zhang et al. 2 citations

Ketamine, an antagonist of N-methyl-D-aspartate receptor, is extensively employed in pediatric anesthesia. Multiple studies have shown that repeated ketamine exposure induces neuroapoptosis, synaptic changes and cognitive deficits during neurodevelopment. Therefore, it is essential to elucidate the mechanisms of ketamine-induced neurotoxicity and develop therapies to mitigate its harmful...

DOI: 10.1016/j.toxlet.2025.02.012 (opens in new tab) Full text (opens in new tab) Disc1 Erk/creb pathway Gsk-3β/β-catenin pathway Neurotoxicity +5

Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans

Toxicology Letters June 12, 2024 Joachim Neumann, Kiril Dimov, Karyna Azatsian et al. 5 citations

Several fungi belonging to the genus Psilocybe, also called "magic mushrooms", contain the hallucinogenic drugs psilocybin and psilocin. They are chemically related to serotonin (5-HT). In addition to being abused as drugs, they are now also being discussed or used as a treatment option for depression. Here, we hypothesized that psilocybin and psilocin may act also on cardiac serotonin...

2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system.

Toxicology Letters November 1, 2021 K. S. Yoon, Hye Jin Cha, S. Choi et al.

Two new psychoactive substances (NPSs) classified as phenethylamines, namely 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH), are being abused by people seeking recreational hallucinogens. These NPSs may cause serious health problems as their adverse effects are not known in most cases....

Cardiotoxic effects of [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol: Short title: QT prolongation by 4-acetoxy-DET and 4-hydroxy-MET.

Toxicology Letters November 6, 2019 K. S. Yoon, Jin-Moo Lee, Young-Hoon Kim et al.

Two synthetic tryptamines, namely [3-[2-(diethylamino)ethyl]-1H-indol-4-yl] acetate (4-AcO-DET) and 3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol (4-HO-MET), are abused by individuals seeking recreational hallucinogens. These new psychoactive substances (NPSs) can cause serious health problems because their adverse effects are mostly unknown. In the present study, we evaluated the...

2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo.

Toxicology Letters April 1, 2019 K. S. Yoon, Jaesuk Yun, Young-Hoon Kim et al.

Two emerging psychoactive substances, 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe), are being abused, leading to fatal and non-fatal intoxications. However, most of their adverse effects have been reported anecdotally. In the present study, cardiotoxicity was evaluated through...

Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A.

Toxicology Letters October 1, 2018 Carolina Noble, Niels Bjerre Holm, Marie Mardal et al. 17 citations

Bromo-dragonfly is a benzodifuran derivative known as one of the most potent 5-HT2A-receptor agonists within this chemical class, with long-lasting effects of up to 2-3 days. In addition to hallucinogenic effects, the drug is a potent vasoconstrictor, resulting in severe adverse effects, such as necrosis of the limbs. In some cases, intoxication has had fatal outcomes. Little is known about the...

DOI: 10.1016/j.toxlet.2018.07.018 (opens in new tab) Full text (opens in new tab) Benzodifuran High-resolution mass spectrometry Inhibition Metabolism +2

Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach.

Toxicology Letters March 15, 2018 Achim T. Caspar, Markus R Meyer, Hans H Maurer

A huge number of new chemical derivatives of known drugs of abuse, so-called new psychoactive substances (NPS), are sold and consumed without prior preclinical and clinical testing. For assessing the elimination behaviors, determination of the kinetic constants Km and Vmax of the cytochrome P450 (CYP) isoforms involved in the hepatic metabolism of NPS could help to predict their contributions...

DOI: 10.1016/j.toxlet.2017.12.017 (opens in new tab) Full text (opens in new tab) Michaelis-menten kinetic Nbome Relative activity factor Substrate depletion approach

In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks.

Toxicology Letters April 15, 2017 Lea Wagmann, Simon D. Brandt, Pierce V. Kavanagh et al.

Tryptamines have emerged as new psychoactive substances (NPS), which are distributed and consumed recreationally without preclinical studies or safety tests. Within the alpha-methylated tryptamines, some of the psychoactive effects of the prototypical alpha-methyltryptamine (AMT) have been described decades ago and a contributing factor of its acute toxicity appears to involve the inhibition of...

DOI: 10.1016/j.toxlet.2017.03.007 (opens in new tab) Full text (opens in new tab) Drugs of abuse Ic50 value Lc–hr-ms/ms Mao inhibition

Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.

Toxicology Letters January 22, 2016 Andrea E. Steuer, Martina I. Boxler, Lorena Stock et al.

Neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA) is still controversially discussed. Formation of reactive oxygen species e.g. based on elevated dopamine (DA) concentrations and DA quinone formation is discussed among others. Inhibition potential of MDMA metabolites regarding neurotransmitter degradation by catechol-O-methyltransferase and sulfotransferase was described previously....

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

Toxicology Letters November 17, 2015 Julia Dinger, Campbell Woods, Simon D. Brandt et al.

New psychoactive substances (NPS) are not tested for their cytochrome P450 (CYP) inhibition potential before consumption. Therefore, this potential was explored for tryptamine-derived NPS (TDNPS) including alpha-methyl tryptamines (AMTs), dimethyl tryptamines (DMTs), diallyl tryptamines (DALTs), and diisopropyl tryptamines (DiPTs) using test substrates preferred by the Food and Drug...

Methoxetamine--a novel recreational drug with potent hallucinogenic properties.

Toxicology Letters November 4, 2014 Jolanta B. Zawilska

Methoxetamine is one of the constantly growing group of novel psychoactive substances that has emerged in recent years. The compound belongs to the arylcyclohexylamine class, which is used for its recreational and psychedelic effects. Methoxetamine is a structural analogue of ketamine, with a much longer duration of action and intensity of effects, and has been extensively advertised as its...

DOI: 10.1016/j.toxlet.2014.08.011 (opens in new tab) Full text (opens in new tab) Hallucinogenic/dissociative drugs Methoxetamine Novel psychoactive substances Toxidrome

5-Iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.

Toxicology Letters March 27, 2013 Maurizio Coppola, Raffaella Mondola 20 citations

In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p-iodoamphetamine producing MDMA-like effects. The aim of this paper is to summarize the clinical,...

Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.

Toxicology Letters February 4, 2013 Patrícia Silva Ferreira, Tiago Bernandes Nogueira, Vera Marisa Costa et al.

"Ecstasy" (3,4-methylenedioxymethamphetamine or MDMA) is a widely abused recreational drug, reported to produce neurotoxic effects, both in laboratory animals and in humans. MDMA metabolites can be major contributors for MDMA neurotoxicity. This work studied the neurotoxicity of MDMA and its catechol metabolites, α-methyldopamine (α-MeDA) and N-methyl-α-methyldopamine (N-Me-α-MeDA) in human...

Cardiotoxicity induced in mice by long term ketamine and ketamine plus alcohol treatment.

Toxicology Letters November 30, 2011 W M Chan, Y Liang, Maria S M Wai et al.

Increased use of ketamine as a recreational drug in rave party has raised lots of social concerns. Although its toxicity on the central nervous system (CNS) and urinary system had been reported, its potential adverse effects on the heart is still not addressed. Using our long term ketamine addiction model in which, 1-month-old ICR mice were given ketamine intraperitoneally (i.p. 30 mg/kg) for...

Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermia.

Toxicology Letters October 10, 2011 Sandra L Hrometz, Karen Thatcher, Jeremy A Ebert et al.

MDMA (3,4-methylenedioxymethamphetamine) induces thermogenesis in a mitochondrial uncoupling protein 3-dependent manner. There is evidence that this hyperthermia is mediated in part by the lipolytic release of free fatty acids, that subsequently activate uncoupling protein 3 in skeletal muscle mitochondria. We hypothesize that atrial natriuretic peptide (ANP), a strong lipolytic mediator, may...

Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.

Toxicology Letters October 8, 2009 Markus R Meyer, Frank T. Peters, Hans H Maurer

3,4-Methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) are chiral designer drugs distributed on the illicit drug market and they are also N-dealkyl metabolites of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy, Adam), 3,4-methylenedioxyethylamphetamine (MDEA, Eve), and N-methyl-benzodioxolyl-butanamine (MBDB, Eden), respectively. MDA and BDB are mainly metabolized via...

Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.

Toxicology Letters April 21, 2008 Miroslava Rohanová, Tomáš Páleníček, Marie Balíková 33 citations

The psychedelic compound 4-bromo-2,5-dimethoxyphenethylamine (2C-B) has appeared as an agent in drug abuse or overdose cases in humans. The human pharmacokinetics of this drug is unknown and only partial information is available on its metabolites. Our experimental study was focused on the disposition and kinetic profile of 2C-B in rats after subcutaneous administration using a GC-MS validated...

DOI: 10.1016/j.toxlet.2008.01.017 (opens in new tab) Full text (opens in new tab) 2c-b Psychedelic compound Original compound Pharmacokinetics +14

5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.

Toxicology Letters April 5, 2007 Chiharu Sogawa, Norio Sogawa, J Tagawa et al. 47 citations

5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a synthetic orally active hallucinogenic tryptamine derivative, known also as Foxy or Foxy methoxy. However, few studies have examined its effects in vitro. In the present study, we investigated the actions of 5-MeO-DIPT against monoamine neurotransmitter transporters, including the transporters for dopamine (DAT), norepinephrine (NET), and...

The role of the NMDA synapse in general anesthesia.

Toxicology Letters November 23, 1998 H Flohr, U Glade, D Motzko

A theory of anesthesia is presented. It consists of four hypotheses. (1) The occurrence of states of consciousness causally depends on the formation of transient higher-order, self-referential mental representations. The occurrence of such states is identical with the appearance of conscious phenomena. Loss of consciousness will occur, if the brain's representational activity falls below a...

Anesthesia, consciousness and hydrophobic pockets--a unitary quantum hypothesis of anesthetic action.

Toxicology Letters November 23, 1998 Stuart Hameroff

1. A consensus view holds that anesthetics act by van der Waals forces in hydrophobic pockets of select brain proteins to ablate consciousness. 2. What is consciousness? Enigmatic features of consciousness (e.g. 'qualia', binding, non-computability, pre-conscious-->conscious transition, nondeterministic free will) may be explained by the occurrence of quantum coherent states in the brain. 3....